NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
Australia
· Delayed Price · Currency is AUD 0.0540
+0.0010 (1.89%)
May 14, 2025, 11:15 AM AEST
ASX:NSB Revenue
NeuroScientific Biopharmaceuticals had revenue of 2.21M AUD in the twelve months ending December 31, 2024, down -41.71% year-over-year. In the fiscal year ending June 30, 2024, NeuroScientific Biopharmaceuticals had annual revenue of 2.21M, down -55.34%.
Revenue
2.21M
Revenue Growth
-41.71%
P/S Ratio
3.47
Revenue / Employee
n/a
Employees
n/a
Market Cap
7.66M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 17.12B |
| Ansell | 3.00B |
| Regis Healthcare | 1.10B |